Panel
Research to business
About the panel
The transition from academic research to a commercial business (often called Research to Business or R2B), and its subsequent evolution into continuous Research and Development (R&D), represents the modern lifecycle of innovation.
Rather than treating commercialization as a final, one-time step, successful organizations now embed business metrics directly into the scientific process. This creates a loop where market feedback constantly informs ongoing R&D, turning raw science into scalable products. These changes call for renewed research planning processes, adapted funding methods and tools, and reimagined project structures — ultimately, a challenge for the entire ecosystem.
Speakers
Introduction and moderation
Isabelle Hippolyte
ANR France
Discussion
Vincenzo Lorusso
EU DG Research and Innovation
Lukovi Seke
African Union Development Agency-NEPAD
Gianpiero Menza
Senior Manager, Partnerships & Innovative Finance, Alliance Bioversity/CGIAR
Antonella Autino
Coordinator of the PRIMA Programme